422 related articles for article (PubMed ID: 10555913)
21. A possible defective estimation of antineutrophil cytoplasmic antibodies in systemic lupus erythematosus due to the coexistence of periodontitis: preliminary observations.
Novo E; García-Mac Gregor E; Nava S; Perini L
P R Health Sci J; 1997 Dec; 16(4):369-73. PubMed ID: 9547827
[TBL] [Abstract][Full Text] [Related]
22. Antineutrophil cytoplasmic antibody (ANCA) testing of routine sera varies in different laboratories but concordance is greater for cytoplasmic fluorescence (C-ANCA) and myeloperoxidase specificity (MPO-ANCA).
Pollock W; Jovanovich S; Savige J
J Immunol Methods; 2009 Aug; 347(1-2):19-23. PubMed ID: 19490915
[TBL] [Abstract][Full Text] [Related]
23. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis.
Gao Y; Ye H; Yu F; Guo XH; Zhao MH
Clin Immunol; 2005 Oct; 117(1):87-93. PubMed ID: 16019262
[TBL] [Abstract][Full Text] [Related]
24. [Detection of antineutrophil cytoplasmic antibodies for the values of Wegener's granulomatosis diagnosis and activity judgment].
Zhang X; Jiang M; Chui J; Wang H; Ma J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):284-7. PubMed ID: 10453568
[TBL] [Abstract][Full Text] [Related]
25. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of antineutrophil cytoplasmic antibodies during treatment with benzylthiouracil.
Sghiri R; Ouertani M; Ben Hsine H; Slim I; Chaieb L; Ghedira I
Pathol Biol (Paris); 2009 Jul; 57(5):410-4. PubMed ID: 19201108
[TBL] [Abstract][Full Text] [Related]
27. Antineutrophil cytoplasmic antibodies in juvenile chronic arthritis.
Mulder L; van Rossum M; Horst G; Limburg P; de Graeff-Meeder ER; Kuis W; Kallenberg C
J Rheumatol; 1997 Mar; 24(3):568-75. PubMed ID: 9058667
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies to myeloperoxidase in systemic sclerosis.
Locke IC; Worrall JG; Leaker B; Black CM; Cambridge G
J Rheumatol; 1997 Jan; 24(1):86-9. PubMed ID: 9002016
[TBL] [Abstract][Full Text] [Related]
29. [Antineutrophil cytoplasmic antibodies in patients with diffuse diseases of connective tissue].
Dadonene I; Redaĭtene E; Shaulauskene I; Kirdaĭte G; Vasiliauskene L
Ter Arkh; 2002; 74(5):38-43. PubMed ID: 12087904
[TBL] [Abstract][Full Text] [Related]
30. Antineutrophil cytoplasmic antibodies in synovial fluid and in serum of patients with rheumatoid arthritis and other types of synovitis.
Afeltra A; Sebastiani GD; Galeazzi M; Caccavo D; Ferri GM; Marcolongo R; Bonomo L
J Rheumatol; 1996 Jan; 23(1):10-5. PubMed ID: 8838502
[TBL] [Abstract][Full Text] [Related]
31. Antineutrophil cytoplasmic autoantibodies (ANCA)--markers in diagnosis and monitoring systemic vasculitides.
Cristea A; Badea T; Bodizs G; Olinic N
Rom J Intern Med; 1995; 33(1-2):37-46. PubMed ID: 8535351
[TBL] [Abstract][Full Text] [Related]
32. Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis.
Lin W; Chen M; Zhao MH
Autoimmunity; 2009 Mar; 42(3):198-202. PubMed ID: 19301200
[TBL] [Abstract][Full Text] [Related]
33. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.
Liu LJ; Chen M; Yu F; Zhao MH; Wang HY
Nephrology (Carlton); 2008 Oct; 13(7):629-35. PubMed ID: 18775059
[TBL] [Abstract][Full Text] [Related]
34. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
Holle JU; Hellmich B; Backes M; Gross WL; Csernok E
Ann Rheum Dis; 2005 Dec; 64(12):1773-9. PubMed ID: 15843447
[TBL] [Abstract][Full Text] [Related]
35. Study of anti-neutrophil cytoplasmic antibodies in patients with thromboangiitis obliterans (Buerger's disease).
Halacheva KS; Manolova IM; Petkov DP; Andreev AP
Scand J Immunol; 1998 Nov; 48(5):544-50. PubMed ID: 9822265
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease.
Merkel PA; Polisson RP; Chang Y; Skates SJ; Niles JL
Ann Intern Med; 1997 Jun; 126(11):866-73. PubMed ID: 9163287
[TBL] [Abstract][Full Text] [Related]
37. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies.
Vermeersch P; Vervaeke S; Blockmans D; van Hoovels L; Mariën G; Vanmaele H; Bossuyt X
Clin Chim Acta; 2008 Nov; 397(1-2):77-81. PubMed ID: 18708041
[TBL] [Abstract][Full Text] [Related]
38. Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis.
Chin HJ; Ahn C; Lim CS; Chung HK; Lee JG; Song YW; Lee HS; Han JS; Kim S; Lee JS
Am J Nephrol; 2000; 20(1):57-63. PubMed ID: 10644870
[TBL] [Abstract][Full Text] [Related]
39. [Anti-neutrophil cytoplasmic antibody--enzyme immunosorbent assay].
Arimura Y; Marumo T; Fujii A; Nakabayashi K; Nagasawa T
Rinsho Byori; 2001 Jun; 49(6):571-4. PubMed ID: 11452543
[TBL] [Abstract][Full Text] [Related]
40. Antigenic specificity of anti-neutrophil cytoplasmic antibody.
Fu HL; Hsu TC; Chang CC; Tsay GJ
J Formos Med Assoc; 2001 Jan; 100(1):35-9. PubMed ID: 11265258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]